Amal S. El‐Shal

1.3k total citations
36 papers, 936 citations indexed

About

Amal S. El‐Shal is a scholar working on Molecular Biology, Genetics and Surgery. According to data from OpenAlex, Amal S. El‐Shal has authored 36 papers receiving a total of 936 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Genetics and 7 papers in Surgery. Recurrent topics in Amal S. El‐Shal's work include Mesenchymal stem cell research (9 papers), Tissue Engineering and Regenerative Medicine (5 papers) and MicroRNA in disease regulation (5 papers). Amal S. El‐Shal is often cited by papers focused on Mesenchymal stem cell research (9 papers), Tissue Engineering and Regenerative Medicine (5 papers) and MicroRNA in disease regulation (5 papers). Amal S. El‐Shal collaborates with scholars based in Egypt, Saudi Arabia and Indonesia. Amal S. El‐Shal's co-authors include Sally M. Shalaby, Doaa Mohammed Youssef, Somia H. Abd‐Allah, Sahar M. Abdel Galil, Ayman Shafei, Mahmoud Ali, Heba F. Pasha, Laila M. Sherief, Hanan S. Sherbiny and Yousri M. Hussein and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gene and The International Journal of Biochemistry & Cell Biology.

In The Last Decade

Amal S. El‐Shal

36 papers receiving 922 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amal S. El‐Shal Egypt 19 374 219 215 184 115 36 936
Jie Cheng China 21 467 1.2× 160 0.7× 115 0.5× 148 0.8× 92 0.8× 86 1.2k
Hyuck Hoon Kwon South Korea 26 595 1.6× 162 0.7× 188 0.9× 157 0.9× 230 2.0× 58 2.1k
Wujun Xue China 17 359 1.0× 120 0.5× 179 0.8× 309 1.7× 187 1.6× 57 919
Sally M. Shalaby Egypt 26 431 1.2× 257 1.2× 230 1.1× 225 1.2× 201 1.7× 70 1.4k
Iman Razeghian‐Jahromi Iran 15 281 0.8× 103 0.5× 169 0.8× 175 1.0× 64 0.6× 59 801
A. van Caam Netherlands 18 595 1.6× 237 1.1× 83 0.4× 197 1.1× 135 1.2× 45 1.4k
Silvia Sancilio Italy 21 390 1.0× 108 0.5× 100 0.5× 110 0.6× 121 1.1× 46 945
Evgenios Goussetis Greece 16 262 0.7× 74 0.3× 335 1.6× 168 0.9× 99 0.9× 52 948
Takanori Shinjo Japan 18 454 1.2× 203 0.9× 114 0.5× 136 0.7× 155 1.3× 41 1.0k

Countries citing papers authored by Amal S. El‐Shal

Since Specialization
Citations

This map shows the geographic impact of Amal S. El‐Shal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amal S. El‐Shal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amal S. El‐Shal more than expected).

Fields of papers citing papers by Amal S. El‐Shal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amal S. El‐Shal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amal S. El‐Shal. The network helps show where Amal S. El‐Shal may publish in the future.

Co-authorship network of co-authors of Amal S. El‐Shal

This figure shows the co-authorship network connecting the top 25 collaborators of Amal S. El‐Shal. A scholar is included among the top collaborators of Amal S. El‐Shal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amal S. El‐Shal. Amal S. El‐Shal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Youssef, Doaa Mohammed, et al.. (2023). Evaluation of ceftriaxone pharmacokinetics in hospitalized Egyptian pediatric patients. European Journal of Pediatrics. 182(10). 4407–4420. 3 indexed citations
2.
El‐Shal, Amal S., et al.. (2022). Utility of muscle ultrasound in nutritional assessment of children with nephrotic syndrome. Pediatric Nephrology. 38(6). 1821–1829. 3 indexed citations
3.
El‐Shal, Amal S., et al.. (2019). Role of a novel circulatory RNA‐based biomarker panel expression in ovarian cancer. IUBMB Life. 71(12). 2031–2047. 8 indexed citations
4.
El‐Shal, Amal S., et al.. (2019). Ameliorative effect of combined low dose of Pioglitazone and omega‐3 on spermatogenesis and steroidogenesis in diabetic rats. Journal of Cellular Biochemistry. 121(2). 1524–1540. 21 indexed citations
5.
El‐Shal, Amal S., et al.. (2018). Serum miRNA-27a and miRNA-18b as potential predictive biomarkers of hepatitis C virus-associated hepatocellular carcinoma. Molecular and Cellular Biochemistry. 447(1-2). 125–136. 34 indexed citations
7.
Shafei, Ayman, et al.. (2017). Mechanistic effects of mesenchymal and hematopoietic stem cells: New therapeutic targets in myocardial infarction. Journal of Cellular Biochemistry. 119(7). 5274–5286. 26 indexed citations
8.
Shalaby, Sally M., et al.. (2017). Promoter methylation and expression of DNA repair genes MGMT and ERCC1 in tissue and blood of rectal cancer patients. Gene. 644. 66–73. 21 indexed citations
9.
Shalaby, Sally M., et al.. (2017). Combined Wharton’s jelly derived mesenchymal stem cells and nerve guidance conduit: A potential promising therapy for peripheral nerve injuries. The International Journal of Biochemistry & Cell Biology. 86. 67–76. 29 indexed citations
10.
Shafei, Ayman, et al.. (2017). Mesenchymal stem cell therapy: A promising cell‐based therapy for treatment of myocardial infarction. The Journal of Gene Medicine. 19(12). 132 indexed citations
11.
Youssef, Doaa Mohammed, et al.. (2016). MicroRNA–21 as a novel biomarker in diagnosis and response to therapy in asthmatic children. Molecular Immunology. 71. 107–114. 67 indexed citations
12.
Shalaby, Sally M., et al.. (2016). Comparing the effects of MSCs and CD34+ cell therapy in a rat model of myocardial infarction. IUBMB Life. 68(5). 343–354. 11 indexed citations
13.
Abd‐Allah, Somia H., et al.. (2014). Effect of bone marrow–derived mesenchymal stromal cells on hepatoma. Cytotherapy. 16(9). 1197–1206. 25 indexed citations
14.
Shalaby, Sally M., et al.. (2014). Mesenchymal stromal cell injection protects against oxidative stress in Escherichia coli–induced acute lung injury in mice. Cytotherapy. 16(6). 764–775. 54 indexed citations
15.
Youssef, Doaa Mohammed & Amal S. El‐Shal. (2013). Multidrug Resistance-1 Gene Polymorphisms in Steroid Resistance Nephrotic Syndrome with Different Pathology. 1(1). 1–3. 1 indexed citations
16.
Youssef, Doaa Mohammed, et al.. (2013). Multi-drug resistance-1 gene polymorphisms in nephrotic syndrome: Impact on susceptibility and response to steroids. Gene. 530(2). 201–207. 26 indexed citations
17.
Abd‐Allah, Somia H., Sally M. Shalaby, Heba F. Pasha, et al.. (2013). Mechanistic action of mesenchymal stem cell injection in the treatment of chemically induced ovarian failure in rabbits. Cytotherapy. 15(1). 64–75. 94 indexed citations
19.
El‐Shal, Amal S., et al.. (2013). Association of microRNAs genes polymorphisms with rheumatoid arthritis in Egyptian female patients. Joint Bone Spine. 80(6). 626–631. 40 indexed citations
20.
El‐Shal, Amal S., et al.. (2013). Role of vitamin D receptor gene polymorphisms and serum 25-hydroxyvitamin D level in Egyptian female patients with systemic lupus erythematosus. Molecular Biology Reports. 40(11). 6151–6162. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026